IA
CRL icon

Icon Advisers’s Charles River Laboratories CRL Stock Holding History

Icon Advisers’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,000
Closed -$324K – 368
2017
Q3 		$324K Hold
3,000
– – 0.02% 352
2017
Q2 		$303K Hold
3,000
– – 0.02% 364
2017
Q1 		$270K Sell
3,000
-21,800
-88% -$1.85M 0.02% 369
2016
Q4 		$1.89M Hold
24,800
– – 0.13% 211
2016
Q3 		$2.07M Buy
24,800
+15,500
+167% +$1.3M 0.14% 199
2016
Q2 		$767K Buy
+9,300
New +$766K 0.05% 279

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Icon Advisers's CRL Position: Q4 2017 in Review

Icon Advisers sold out of Charles River Laboratories (CRL) in Q4 2017, closing a stake of 3,000 shares — an estimated $324K sold.

Icon Advisers first reported a position in CRL in Q2 2016 and held it in 6 quarters. The position peaked at $2.07M in Q3 2016. 339 funds tracked by Wall St. Rank hold CRL as of Q4 2017.

  • Icon Advisers reported no remaining Charles River Laboratories position as of Q4 2017 after selling out during the quarter.
  • Icon Advisers sold 3,000 Charles River Laboratories shares in Q4 2017, an estimated $324K.
  • Icon Advisers first reported a position in Charles River Laboratories in Q2 2016 and held it in 6 quarters.
  • Icon Advisers's Charles River Laboratories position peaked at $2.07M in Q3 2016.
  • 339 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2017.

Based on Icon Advisers's 13F filing for Q4 2017, filed 6 Feb 2018.